|
USP25 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.52280000000383E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.260520E-03 |
| Normal-vs-Stage2 |
1.202590E-04 |
| Normal-vs-Stage3 |
3.816700E-04 |
| Normal-vs-Stage4 |
1.802960E-04 |
| Stage1-vs-Stage2 |
4.445800E-02 |
| Stage1-vs-Stage3 |
3.372600E-01 |
| Stage1-vs-Stage4 |
1.452840E-01 |
| Stage2-vs-Stage3 |
2.264000E-01 |
| Stage2-vs-Stage4 |
4.682000E-01 |
| Stage3-vs-Stage4 |
6.297400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.371400E-04 |
| Normal-vs-AfricanAmerican |
1.908400E-01 |
| Normal-vs-Asian |
1.862400E-02 |
| Caucasian-vs-AfricanAmerican |
5.776000E-01 |
| Caucasian-vs-Asian |
7.886400E-01 |
| AfricanAmerican-vs-Asian |
7.561000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.50260000000491E-05 |
| Normal-vs-Female |
4.012800E-04 |
| Male-vs-Female |
9.940100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.110220E-02 |
| Normal-vs-Age(41-60Yrs) |
1.002680E-04 |
| Normal-vs-Age(61-80Yrs) |
4.23969999996388E-06 |
| Normal-vs-Age(81-100Yrs) |
2.299400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.195170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.290110E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.295350E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.942760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.702600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.508200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.922600E-01 |
| Classical-VS-Follicular |
2.58959997889718E-09 |
| Classical-VS-Other |
3.113600E-01 |
| Classical-VS-Normal |
4.384100E-02 |
| Tall-VS-Follicular |
6.195900E-04 |
| Tall-VS-Other |
3.490000E-01 |
| Tall-VS-Normal |
9.922000E-02 |
| Follicular-VS-Other |
3.407000E-01 |
| Follicular-VS-Normal |
1.73299996575338E-09 |
| Other-VS-Normal |
4.838100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.97759999948688E-07 |
| Normal-vs-N1 |
5.698600E-03 |
| N0-vs-N1 |
3.505600E-01 |
|
|
